Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Ashland Eyes Sale Of Two Businesses
by Michael McCoy
July 29, 2013
| A version of this story appeared in
Volume 91, Issue 30
Specialty chemical maker Ashland is considering its options, including a sale, for its water technologies business and has retained Citi to assist in the process. The business contributed 21% of Ashland’s $8.0 billion in sales for the 12 months ending June 30 but only 12% of its before-tax earnings. Separately, the company has initiated a process to sell its elastomers business, which had about $330 million in sales in the same 12-month period.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X